The controlling shareholder's illegal occupation funds totaling about 290 million yuan of biological valleys and resignation of two executives and two executives resigned

On July 25, the Biological Valley (BJ833266, the stock price of 7.96 yuan, and a market value of 1.019 billion yuan) issued an announcement stating that the company's chairman Lin Yanhe, the secretary of the board of directors Yang Zhiling, and the chairman of the board of supervisors, and Cai Zeqiu, submitted a resignation report on July 23.

"Daily Economic News" reporter noticed that the previous biological Valley was punished by the Bei Stock Exchange for violations of regulations.

It is worth noting that Xu Tianshui, the new chairman of Biological Valley, joined the company in July 2022. From his employment to the chairman, he was less than one month before and after.

The actual controller of the company will change

According to the Biological Valley Announcement, the company's chairman, secretary of the board of directors, and chairman of the board of supervisors submitted the resignation report on July 23, and the resignation of these three people took effect on July 24. The reason for Lin Yanhe's resignation is "personal reasons", and the reasons for the resignation of Yang Zhiling and Cai Zeqiu are both "work reasons".

Lin Yanhe's actual controller of Biological Valley, as of the end of the first quarter of 2022, he directly held 16.84%of Biological Valley, and his company holding 23.44%of Biological Valley shares in Shenzhen Jinshajiang Investment Co., Ltd.

The annual report of Bio Valley shows that Lin Yan and born in 1964. In the late 1980s, Lin Yanhe worked at Shenzhen Medical Production and Supply Corporation, and then developed in Shenzhen. By 2007, Lin Yanhe began to serve as chairman of the former Biological Valley Yunnan Biological Valley Lantern Pharmaceutical Co., Ltd.. After the restructuring of the biological valley, Lin Yanhe also served as the chairman until 2022.

In contrast, Yang Zhiling has a short time as the secretary of the Biological Valley's board of directors, less than one month. Yang Zhiling has served as the director of the General Economic Council, the manager of the human resources department, the administrative director and deputy general manager since 1998. At the end of June 2022, He Yuan, secretary and chief financial officer of Biological Valley, resigned. Beginning on June 30, 2022, Biological Valley hired Yang Zhiling as the director.

On July 25, 2022, the Biological Valley issued an announcement saying that the company's board of directors elected Xu Tianshui as the chairman of the company and Lin Yanhe for other positions of the company (co -chairman). At the same time, Xu Tianshui was hired as secretary of the company's board of directors.

It is worth noting that Xu Tianshui was born in 1986. According to the Biological Valley announcement, Xu Tianshui's previous resumes were mostly in the financial industry. Investment managers and other positions. Xu Tianshui joined the Biological Valley in July 2022 as assistant to the general manager of the Biology Valley.

In other words, from Xu Tianshui's entry to biological valley to Rongsheng Chairman, less than one month before and after.

According to the previous announcement, on June 30, 2022, Shenzhen Jinshajiang Investment Co., Ltd. and Xinyi Capital Fund Management (Shenzhen) Co., Ltd. (hereinafter referred to as Xinyi Capital) signed the "Share Transfer Agreement". The approximately 11.71 million biological valley shares (about 9.15%of the total share capital) hold it to a limited partnership of new capital as a partnership of executive affairs -the Communist Yingcheng Xinyi Freshman Investment Partnership (Limited Partnership). On the same day, Lin Yanhe reached the "Voting Rights Entrustment Agreement" with Xinyu Capital. Through the voting right entrustment, the total of 24.55 million biological valley shares (about 19.18%of the total share capital) held the voting right to entrust the new meaning Capital exercise.

If the above transfer is completed, the actual controller of the Biological Valley will also be changed from Lin Yanhe to Wang Mei, a shareholder of New Capital. Xu Tianshui, the new chairman of the Biology Valley, has recently been the director of the New Capital Finance Marketing Department.

Earlier by the violation of the rules, it was punished by the Bei Stock Exchange

Since 2022, the biological valley has been in trouble. In April, the Biological Valley received the "Administrative Regulatory Measures Decisions" by the Yunnan Securities Regulatory Bureau, because of Shenzhen Jinshajiang Investment Co., Ltd. occupied the biological valley funds.

"Daily Economic News" reporter noticed that before the selection of the biological valley was listed, in other receivables in 2019, the amount of "exchanges" reached 57.797 million yuan.

The National Stock Transfer Company requested the Biology Valley in its "Inquiry Letter": "There are 57.7697 million yuan in receivables in other receivables, explaining the transaction background, transaction objects, reasons for formation, reasons, reasons, reasons, reasons, reasons, reasons, reasons, formation, and formation. The time limit, interest rate and post -period repayment situation, whether there is a relationship with the exchanges and whether the review procedure is performed. "

According to the "Daily Economic News" previously reported, Yunnan Lin Yanfang Dai Pharmaceutical Technology Co., Ltd. ranked first in other receivables at the time of the biological valley, with about 30 million yuan between the biological valley. Qixinbao Information showed that the supervisor of Yunnan Lin Yanfang Dai Pharmaceutical Technology Co., Ltd. was Lin Yantao, and the indirect shareholders were Lin Yanfang. In the public offering of the shares, the relationship between Lin Yantao and the actual controller Lin Yanhe, the actual controller of the biological valley- "Lin Yantao's key managers of the company's actual controller Lin Yan and the company controlled by the company."

Biological Valley said that in October 2019, in order to support the development of the enterprise in the Maitreya Industrial Park, the company provided a loan of 30 million yuan to Yunnan Lin Yanfang Dai Pharmaceutical Technology Co., Ltd., and the borrowing interest rate was 20%of the bank's benchmark borrowing interest rate during the same period. As of public issuance of shares instructions, the borrowing and interest have been recovered.

However, similar incidents staged again. From August 27, 2021, Shenzhen Jinshajiang Investment Co., Ltd. actually occupied biological valley funds by investing in wealth management products and endorsement bank acceptance bills, totaling about 290 million yuan.In July 2022, the Peking Stock Exchange gave the biological valley and related responsible subject discipline.

Daily Economic News

- END -